These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 4064030

  • 1. Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage.
    Salvati F, Antilli A, Cruciani AR, Pau F, Flore F, Munno R, De Angelis G, Cipri A, Pigorini F.
    Cancer Detect Prev; 1985; 8(1-2):111-4. PubMed ID: 4064030
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer.
    Spinazzi A, Soresi E, Boffi R, Nonis A, Noseda A, Cobelli S, Scanni A.
    Cancer Detect Prev; 1994; 18(3):209-20. PubMed ID: 8076383
    [Abstract] [Full Text] [Related]

  • 3. [Distribution and prognostic value of CEA and TPA in cancer of the lung].
    Leonardo E, Dogliotti C, Mancuso M, Sanfilippo B, Oliaro A.
    Minerva Med; 1986 Mar 17; 77(11):375-9. PubMed ID: 3703330
    [Abstract] [Full Text] [Related]

  • 4. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR, Zhang X, Xu ZF, Zheng S.
    Ai Zheng; 2002 Feb 17; 21(2):196-9. PubMed ID: 12479076
    [Abstract] [Full Text] [Related]

  • 5. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.
    Bombardieri E, Jotti GS, Cocciolo MG, Mori M, Rusconi A, Rusca M, Seregni E, Becchi G, Fontanesi M, Tardini A.
    Cancer Detect Prev; 1985 Feb 17; 8(1-2):219-26. PubMed ID: 4064041
    [Abstract] [Full Text] [Related]

  • 6. [Clinical significance of CEA levels in lung cancer].
    Noge S, Hara N, Ichinose Y, Ishimatsu T, Motohiro A, Etoh K, Miyake J, Ohta M.
    Gan No Rinsho; 1985 May 17; 31(6 Suppl):616-22. PubMed ID: 2993691
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of tumor markers in breast cancer patients].
    Ito T, Tanaka S, Ban K, Sakai N, Oshita H, Oiwa T, Kanno A, Kashizuka T.
    Gan To Kagaku Ryoho; 1987 Oct 17; 14(10):2917-23. PubMed ID: 3310907
    [Abstract] [Full Text] [Related]

  • 8. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
    Slodkowska J, Szturmowicz M, Rudzinski P, Giedronowicz D, Sakowicz A, Androsiuk W, Zakrzewska-Rowinska E.
    Eur J Cancer Prev; 1998 Feb 17; 7(1):51-60. PubMed ID: 9511851
    [Abstract] [Full Text] [Related]

  • 9. [Tissue polypeptide antigen in serum and tissue in patients with lung cancer].
    Haga E.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr 17; 28(4):595-604. PubMed ID: 2170727
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
    Picardo AL, Diez M, Torres A, Maestro M, Ortega D, Hernando F, Gómez A, Garcia-Asenjo J, Balibrea JL.
    Cancer; 1996 Mar 15; 77(6):1066-72. PubMed ID: 8635125
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Biomarkers and IL-2R in lung cancer.
    Marino P, Preatoni A, Fonticoli L, Parodi M, Tarolo GL.
    Recenti Prog Med; 1990 Nov 15; 81(11):702-4. PubMed ID: 1962891
    [Abstract] [Full Text] [Related]

  • 13. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
    Buccheri G, Ferrigno D.
    J Thorac Cardiovasc Surg; 2001 Nov 15; 122(5):891-9. PubMed ID: 11689793
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V, Björklund B.
    Cancer Detect Prev; 1983 Nov 15; 6(1-2):193-8. PubMed ID: 6883380
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
    Hotta K, Segawa Y, Takigawa N, Kishino D, Saeki H, Nakata M, Mandai K, Eguchi K.
    Anticancer Res; 2000 Nov 15; 20(3B):2177-80. PubMed ID: 10928173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.